Ocular Therapeutix Inc. started an underwritten public offering of $25 million of its common shares.
Cantor Fitzgerald & Co. is acting as the sole book runner for the offering.
Ocular Therapeutix commences $25M common stock offering
Japan M&A By the Numbers: Q4 2023
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise